AlloVir, Inc. (ALVR)

NASDAQ: ALVR · Real-Time Price · USD

9.63

-0.04 (-0.41%)

Feb 21, 2025, 4:00 PM EST - Market closed

AlloVir Employees

AlloVir had 112 employees as of December 31, 2023. The number of employees increased by 6 or 5.66% compared to the previous year.

Employees

112

Change (1Y)

6

Growth (1Y)

5.66%

Revenue / Employee

n/a

Profits / Employee

-$894,616

Market Cap

47.92M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	112	6	5.66%
Dec 31, 2022	106	-1	-0.93%
Dec 31, 2021	107	54	101.89%
Dec 31, 2020	53	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	440,000
Johnson & Johnson	131,900
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	72,000

Employee Rankings

ALVR News

12 days ago - ALLOVIR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AlloVir, Inc. - ALVR - Business Wire
3 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMKR and ALVR on Behalf of Shareholders - GlobeNewsWire
3 months ago - AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina - GlobeNewsWire
5 months ago - Kuehn Law Encourages Investors of AlloVir, Inc. to Contact Law Firm - GlobeNewsWire
1 year ago - FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
1 year ago - FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
1 year ago - MARCH 19 FINAL DEADLINE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
1 year ago - INVESTOR DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire